The fiscal year (FY) 2023 omnibus spending legislation (H.R. 2617) includes all 12 FY2023 spending bills including resources for advancing women's health.
SWHR convened a diverse working group of clinicians, genetic counselors, patient advocates, policy professionals, and industry representatives for a three-day roundtable meeting on eliminating barriers to access and, by extension, reducing health disparities in prenatal care as they relate to ECS and NIPS.
SWHR launched its new Psoriatic Arthritis: Diagnosis and Management in Primary Care Fact Sheet, designed to help both clinicians and patients in their approach to diagnosing and treating PsA.
SWHR was invited to participate in a stakeholder meeting to inform the planning process of President Biden’s proposed Advanced Research Projects Agency for Health (ARPA-H), a new entity that would be tasked with building high-risk, high-reward capabilities or platforms to drive biomedical breakthroughs.
Though sleep is essential to health, the unique barriers faced by women in maintaining good sleep health are often misunderstood or overlooked, according to “Women & Sleep: A Guide for Better Health,” a new resource developed by SWHR.
SWHR was awarded the National Institute of Child Health and Human Development's Director’s Award for its participation as a partner agency in PregSourceTM, a crowdsourcing research project that aims to improve knowledge of pregnancy by collecting information directly from pregnant women.
Imaging provides a window into brain changes due to dementia decades before someone begins to show clinical symptoms of the disease. Volume of the brain gradually declines with advancing age, but this decline takes a faster course in people who experience more cognitive decline than is expected for their age and go on to develop dementia.
An estimated 5.2 million Americans live with Alzheimer’s disease. Of these Americans, 5 million are over the age of 65 years old. AD is the third leading cause of death in older adults, and is the only top 10 cause of death in the U.S. with no disease modifying treatment or proven treatment for prevention.
SWHR convened interdisciplinary thought leaders at the George Washington University Milken School of Public Health for a panel discussion that included patients, practitioners, and the employer perspective.
SWHR announced the unanimous election of Roberta L. Gartside, MD, as the new Chair of its Board of Directors for 2018-2019. As a business leader with a strong commitment to nonprofit service, Dr. Gartside will lead the organization’s mission-based efforts to eliminate imbalances in care for women through science, advocacy, and education.